Business Description
Reliq Health Technologies Inc
NAICS : 541511
SIC : 7721
Description
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery. The firm earns through the supply of mobile device management (MDM) solutions for mobile devices and subscriptions of the iUGO CARE platform to healthcare client. The firm is based in Canada.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.61 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.7 | |||||
| Beneish M-Score | 99999999.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 186.4 | |||||
| 3-Year EBITDA Growth Rate | 24.9 | |||||
| 3-Year EPS without NRI Growth Rate | 28.6 | |||||
| 3-Year FCF Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | 15.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.53 | |||||
| 9-Day RSI | 56.5 | |||||
| 14-Day RSI | 54.66 | |||||
| 6-1 Month Momentum % | -10.53 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.72 | |||||
| Quick Ratio | 1.66 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 20.87 | |||||
| Days Sales Outstanding | 155.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.4 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.65 | |||||
| Operating Margin % | -45.94 | |||||
| Net Margin % | -39.2 | |||||
| ROE % | -64.14 | |||||
| ROA % | -43.43 | |||||
| ROIC % | -79.55 | |||||
| ROC (Joel Greenblatt) % | -133.34 | |||||
| ROCE % | -61.67 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.18 | |||||
| PB Ratio | 13.49 | |||||
| Price-to-Tangible-Book | 14.5 | |||||
| EV-to-EBIT | -28.19 | |||||
| EV-to-EBITDA | -29.02 | |||||
| EV-to-Revenue | 10.97 | |||||
| EV-to-FCF | -15.91 | |||||
| Price-to-Net-Current-Asset-Value | 29 | |||||
| Earnings Yield (Greenblatt) % | -3.55 |
